Clinical trial
Comparing Effectiveness and Safety of Left Atrial Appendage Occlusion for Non-valvular Atrial Fibrillation Patients at High Stroke Risk Unable to Use Oral Anticoagulation Therapy
NCT04676880 is registered in ClinicalTrials.gov with R&D Cardiologie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparing Effectiveness and Safety of Left Atrial Appendage Occlusion for Non-valvular Atrial Fibrillation Patients at High Stroke Risk Unable to Use Oral Anticoagulation Therapy
- Lead sponsor
- R&D Cardiologie
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- January 1, 2021
- Completion date
- November 1, 2026
- Enrollment
- 609 (estimated)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
anticoagulants and bleeding disorders, atrial fibrillation